dacarbazine

Dimethyl Triazeno Imidazol Carboxamide

A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C411" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C411" NCI Thesaurus)

http://purl.bioontology.org/ontology/PDQ/CDR0000039768

Dimethyl Triazeno Imidazol Carboxamide

1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-

5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide

DTIC

dimethyl-triazeno-imidazole carboxamide

5-(dimethyltriazeno)imidazole-4-carboxamide

Dacatic

Deticene

Imidazole Carboxamide Dimethyltriazeno

Fauldetic

5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide

Dacarbazina

Dakarbazin

WR-139007

Dimethyl (triazeno) imidazolecarboxamide

Imidazole Carboxamide

Biocarbazine

Detimedac

DIC

Dimethyl Triazeno Imidazole Carboxamide

Asercit

Dacarbazine - DTIC

Dacarbazina Almirall

4342-03-4

http://purl.bioontology.org/ontology/PDQ/CDR0000041366

http://purl.bioontology.org/ontology/PDQ/CDR0000363628

http://purl.bioontology.org/ontology/PDQ/CDR0000038605

http://purl.bioontology.org/ontology/PDQ/CDR0000039372

http://purl.bioontology.org/ontology/PDQ/CDR0000039351

http://purl.bioontology.org/ontology/PDQ/CDR0000042269

http://purl.bioontology.org/ontology/PDQ/CDR0000041365

http://purl.bioontology.org/ontology/PDQ/CDR0000042552

http://purl.bioontology.org/ontology/PDQ/CDR0000435983

http://purl.bioontology.org/ontology/PDQ/CDR0000039120

http://purl.bioontology.org/ontology/PDQ/CDR0000415314

http://purl.bioontology.org/ontology/PDQ/CDR0000039976

http://purl.bioontology.org/ontology/PDQ/CDR0000042047

http://purl.bioontology.org/ontology/PDQ/CDR0000040471

http://purl.bioontology.org/ontology/PDQ/CDR0000039416

http://purl.bioontology.org/ontology/PDQ/CDR0000038553

http://purl.bioontology.org/ontology/PDQ/CDR0000043252

http://purl.bioontology.org/ontology/PDQ/CDR0000040947

http://purl.bioontology.org/ontology/PDQ/CDR0000038890

http://purl.bioontology.org/ontology/PDQ/CDR0000039432

http://purl.bioontology.org/ontology/PDQ/CDR0000039693

http://purl.bioontology.org/ontology/PDQ/CDR0000041037

http://purl.bioontology.org/ontology/PDQ/CDR0000041036

http://purl.bioontology.org/ontology/PDQ/CDR0000257908

http://purl.bioontology.org/ontology/PDQ/CDR0000042268

http://purl.bioontology.org/ontology/PDQ/CDR0000041941

http://purl.bioontology.org/ontology/PDQ/CDR0000038276

http://purl.bioontology.org/ontology/PDQ/CDR0000041364

http://purl.bioontology.org/ontology/PDQ/CDR0000041377

http://purl.bioontology.org/ontology/PDQ/CDR0000039604

http://purl.bioontology.org/ontology/PDQ/CDR0000041376

http://purl.bioontology.org/ontology/PDQ/CDR0000042139

http://purl.bioontology.org/ontology/PDQ/CDR0000040936

http://purl.bioontology.org/ontology/PDQ/CDR0000040417

http://purl.bioontology.org/ontology/PDQ/CDR0000039452

http://purl.bioontology.org/ontology/PDQ/CDR0000039389

http://purl.bioontology.org/ontology/PDQ/CDR0000041916

http://purl.bioontology.org/ontology/PDQ/CDR0000038841

http://purl.bioontology.org/ontology/PDQ/CDR0000041332

http://purl.bioontology.org/ontology/PDQ/CDR0000039686

http://purl.bioontology.org/ontology/PDQ/CDR0000042013

http://purl.bioontology.org/ontology/PDQ/CDR0000040354

http://purl.bioontology.org/ontology/PDQ/CDR0000041141

http://purl.bioontology.org/ontology/PDQ/CDR0000040472

http://purl.bioontology.org/ontology/PDQ/CDR0000042445

http://purl.bioontology.org/ontology/PDQ/CDR0000442900

http://purl.bioontology.org/ontology/PDQ/CDR0000041277

http://purl.bioontology.org/ontology/PDQ/CDR0000039775

http://purl.bioontology.org/ontology/PDQ/CDR0000042208

http://purl.bioontology.org/ontology/PDQ/CDR0000040946

http://purl.bioontology.org/ontology/PDQ/CDR0000042053

http://purl.bioontology.org/ontology/PDQ/CDR0000042280

http://purl.bioontology.org/ontology/PDQ/CDR0000353183

http://purl.bioontology.org/ontology/PDQ/CDR0000039119

http://purl.bioontology.org/ontology/PDQ/CDR0000361549

http://purl.bioontology.org/ontology/PDQ/CDR0000352012

http://purl.bioontology.org/ontology/PDQ/CDR0000039701

http://purl.bioontology.org/ontology/PDQ/CDR0000257909

http://purl.bioontology.org/ontology/PDQ/CDR0000041140

http://purl.bioontology.org/ontology/PDQ/CDR0000042463

http://purl.bioontology.org/ontology/PDQ/CDR0000042279

http://purl.bioontology.org/ontology/PDQ/CDR0000038434

http://purl.bioontology.org/ontology/PDQ/CDR0000040314

http://purl.bioontology.org/ontology/PDQ/CDR0000042126

http://purl.bioontology.org/ontology/PDQ/CDR0000039390

http://purl.bioontology.org/ontology/PDQ/CDR0000039400

http://purl.bioontology.org/ontology/PDQ/CDR0000038846

C0392206

C1511712

C1511710

C0010927

C1511711

C0728896

C1521711

C1521710

C0728898

C1511709

2018-01-10

A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C411" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C411" NCI Thesaurus)

3188

243

TRD

C411

CDR0000039768

45388

Drug/agent

dacarbazine

T109

T121